Mismatch repair and treatment resistance in ovarian cancer

BACKGROUND: The treatment of ovarian cancer is hindered by intrinsic or acquired resistance to platinum-based chemotherapy. The aim of this study is to determine the frequency of mismatch repair (MMR) inactivation in ovarian cancer and its association with resistance to platinum-based chemotherapy....

Descripción completa

Detalles Bibliográficos
Autores principales: Helleman, Jozien, van Staveren, Iris L, Dinjens, Winand NM, van Kuijk, Patricia F, Ritstier, Kirsten, Ewing, Patricia C, van der Burg, Maria EL, Stoter, Gerrit, Berns, Els MJJ
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1557864/
https://www.ncbi.nlm.nih.gov/pubmed/16879751
http://dx.doi.org/10.1186/1471-2407-6-201

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1557864/
https://www.ncbi.nlm.nih.gov/pubmed/16879751
http://dx.doi.org/10.1186/1471-2407-6-201

Ejemplares similares